Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrated Treatment for Enhancing Growth in Recovery During Adolescence (InTEGRA)

NCT06395467 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06395467 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrated Treatment for Enhancing Growth in Recovery During Adolescence (InTEGRA)
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
November 26, 2024
Completion date
May 31, 2028
Enrollment
294 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, cannabis use disorder